Salud financiera de hoja de balance de Repligen
Salud financiera controles de criterios 5/6
Repligen tiene un patrimonio de accionistas total de $2.0B y una deuda total de $521.6M, lo que sitúa su ratio deuda-patrimonio en 25.9%. Sus activos y pasivos totales son $2.8B y $814.0M respectivamente. El BAIT de Repligen es de $25.7M, por lo que su ratio de cobertura de intereses es de -2.9. Tiene efectivo e inversiones a corto plazo que ascienden a $784.0M.
Información clave
25.9%
Ratio deuda-patrimonio
US$521.61m
Deuda
| Ratio de cobertura de intereses | -2.9x |
| Efectivo | US$783.96m |
| Patrimonio | US$2.02b |
| Total pasivo | US$813.96m |
| Activos totales | US$2.83b |
Actualizaciones recientes sobre salud financiera
Repligen (NASDAQ:RGEN) Has A Pretty Healthy Balance Sheet
Nov 08
We Think Repligen (NASDAQ:RGEN) Can Stay On Top Of Its Debt
Jul 15Repligen (NASDAQ:RGEN) Has A Pretty Healthy Balance Sheet
Apr 15Is Repligen (NASDAQ:RGEN) Using Too Much Debt?
Oct 17Does Repligen (NASDAQ:RGEN) Have A Healthy Balance Sheet?
Jul 17Recent updates
Repligen Corporation's Earnings Preview: Expensive With Mixed Growth Prospects
Nov 12Repligen (NASDAQ:RGEN) Has A Pretty Healthy Balance Sheet
Nov 08Is It Time To Consider Buying Repligen Corporation (NASDAQ:RGEN)?
Oct 14Repligen Corporation's (NASDAQ:RGEN) Intrinsic Value Is Potentially 28% Above Its Share Price
Sep 08Repligen Corporation (NASDAQ:RGEN) Stocks Shoot Up 27% But Its P/S Still Looks Reasonable
Jul 31We Think Repligen (NASDAQ:RGEN) Can Stay On Top Of Its Debt
Jul 15Repligen: Strong Filtration Growth, Offset By Other Challenges
Jul 13Why We're Not Concerned Yet About Repligen Corporation's (NASDAQ:RGEN) 27% Share Price Plunge
Jun 14Is Now The Time To Look At Buying Repligen Corporation (NASDAQ:RGEN)?
Jun 10Repligen Stock: Still Quite Overvalued
May 30Repligen Corporation Just Missed Earnings - But Analysts Have Updated Their Models
May 03Estimating The Intrinsic Value Of Repligen Corporation (NASDAQ:RGEN)
Apr 30Repligen (NASDAQ:RGEN) Has A Pretty Healthy Balance Sheet
Apr 15At US$206, Is Repligen Corporation (NASDAQ:RGEN) Worth Looking At Closely?
Feb 13Estimating The Intrinsic Value Of Repligen Corporation (NASDAQ:RGEN)
Jan 08Why We're Not Concerned About Repligen Corporation's (NASDAQ:RGEN) Share Price
Dec 19What Does Repligen Corporation's (NASDAQ:RGEN) Share Price Indicate?
Nov 01Is Repligen (NASDAQ:RGEN) Using Too Much Debt?
Oct 17Is There An Opportunity With Repligen Corporation's (NASDAQ:RGEN) 22% Undervaluation?
Sep 29Things Look Grim For Repligen Corporation (NASDAQ:RGEN) After Today's Downgrade
Aug 09Does Repligen (NASDAQ:RGEN) Have A Healthy Balance Sheet?
Jul 17Is There Now An Opportunity In Repligen Corporation (NASDAQ:RGEN)?
Jul 03With EPS Growth And More, Repligen (NASDAQ:RGEN) Makes An Interesting Case
Jun 19Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo ($1.1B) de RGEN superan a sus pasivos a corto plazo ($108.4M).
Pasivo a largo plazo: Los activos a corto plazo de RGEN ($1.1B) superan a sus pasivos a largo plazo ($705.6M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: RGEN tiene más efectivo que su deuda total.
Reducción de la deuda: El ratio deuda-patrimonio de RGEN ha crecido de 22% a 25.9% en los últimos 5 años.
Cobertura de la deuda: La deuda de RGEN está bien cubierta por el flujo de caja operativo (31.7%).
Cobertura de intereses: RGEN gana más intereses de los que paga, por lo que la cobertura de pagos de intereses no es preocupante.